Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists.
about
Summary of information on human CYP enzymes: human P450 metabolism data.Coprescription of tamoxifen and medications that inhibit CYP2D6.Inadvertent relaxation of the ductus arteriosus by pharmacologic agents that are commonly used in the neonatal periodRational prescription of drugs within similar therapeutic or structural class for gastrointestinal disease treatment: drug metabolism and its related interactions.Effects of Flos carthami on CYP2D6 and on the Pharmacokinetics of Metoprolol in Rats.New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme.Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2.Influence of hydroxychloroquine on the bioavailability of oral metoprolol[¹¹C]Rhodamine-123: synthesis and biodistribution in rodents.A pharmacokinetic study of etravirine (TMC125) co-administered with ranitidine and omeprazole in HIV-negative volunteersHigh-affinity binding of [3H]cimetidine to a heme-containing protein in rat brain.A Two-Period Open-Label, Single-Dose Crossover Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Between Cimetidine and Inhaled Extrafine CHF 5993.Acute vomiting in cats: rational treatment selection.Fetal serotonin reuptake inhibitor antidepressant exposure: maternal and fetal factors.A therapeutic interaction between cimetidine and clozapine: case study and review of the literature.pH-dependent drug-drug interactions for weak base drugs: potential implications for new drug development.Concurrent use of proton pump inhibitors or H2 blockers did not adversely affect nilotinib efficacy in patients with chronic myeloid leukemia.Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agentHistamine H2-receptor antagonists have no clinically significant effect on the steady-state pharmacokinetics of voriconazole.The effect of repeat dosing with cimetidine on the pharmacokinetics of intravenous granisetron in healthy volunteers.Combination of Mangifera indica L. extract supplementation plus methotrexate in rheumatoid arthritis patients: a pilot study.An aqueous extract of Withania somnifera root inhibits amyloid β fibril formation in vitro.Metabolic interactions between acetaminophen (paracetamol) and two flavonoids, luteolin and quercetin, through in-vitro inhibition studies.Functional expression and comparative characterization of four feline P450 cytochromes using fluorescent substrates.Effect of meal and antisecretory agents on the pharmacokinetics of danoprevir/ritonavir in healthy volunteers.An Overview of Analytical Determination of Diltiazem, Cimetidine, Ranitidine, and Famotidine by UV Spectrophotometry and HPLC Technique
P2860
Q32103802-403118F3-741B-475D-8E73-C1735E5F614CQ33898184-BE3AC218-65AB-4167-849D-DB75E24A8082Q34061751-567341E3-572B-41F3-A25E-6FE925C66FDBQ34233142-9C2A4EC4-1FF6-4C0B-A8F2-6E2319903C1CQ34362562-CA83EB4D-AD77-4C39-9846-3AC01D7B7AACQ34994964-7EF6512B-BBA2-4D8B-B01D-C931396DC93EQ35015993-ECD213DB-780F-4AB3-8629-EF118A0C005EQ36055442-3D3C39FB-57D6-4110-8C86-C65037EB5870Q36339071-C58A9DBB-EDE6-4C43-942F-212E589766A7Q36922216-22B46D8E-FE3A-4706-AF8C-14B342812E61Q36982824-CBDCB88F-309A-45DD-BF94-891AEAAE9189Q37685496-50222BED-FE35-4DD1-9AD6-6FA661BFC387Q37701035-C5A7702A-B57D-434D-9664-55B4D58EAAB7Q38052726-63487E85-9F05-44FB-B4FA-934C541E9B22Q38156174-42FC6D47-47E4-422D-8559-3D16FC96F2DBQ38204680-E1135E6F-1AE1-46A9-867F-48D3219366B6Q41404243-285D6E67-35FD-4EA2-AA81-59AA583373F3Q41668110-8333047B-3BF3-4C7A-B018-87F7E1FE17E3Q41962141-AAE5DB59-2CE7-4E52-8806-0151FED10D76Q44789790-154503D4-0063-4CB3-BB4B-FD5E602DB3A4Q45110020-EB2789DD-3277-4E11-92D4-9632651C9088Q47298268-B36189D7-B698-4A41-9352-D7CA6945056AQ48129215-E1BA8A9F-2086-4B5B-9F79-479C7024BC96Q51328715-E1ADC11B-D2EB-4C4F-8FBB-16E2BAA52861Q51332911-70BDE1E8-EBC0-4B4E-BD7D-DE4C89660FD1Q59009038-8DE8910E-7084-42E3-A94F-41A4223D6B33
P2860
Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Comparative in vitro and in vi ...... 3A by H2-receptor antagonists.
@ast
Comparative in vitro and in vi ...... 3A by H2-receptor antagonists.
@en
type
label
Comparative in vitro and in vi ...... 3A by H2-receptor antagonists.
@ast
Comparative in vitro and in vi ...... 3A by H2-receptor antagonists.
@en
prefLabel
Comparative in vitro and in vi ...... 3A by H2-receptor antagonists.
@ast
Comparative in vitro and in vi ...... 3A by H2-receptor antagonists.
@en
P2093
P1476
Comparative in vitro and in vi ...... 3A by H2-receptor antagonists.
@en
P2093
Agúndez JA
Carrillo JA
Martínez C
P304
P356
10.1016/S0009-9236(99)70129-3
P407
P577
1999-04-01T00:00:00Z